Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Other Operating Expenses (2021)

Historic Other Operating Expenses for Immunocore Holdings (IMCR) over the last 1 years, with Q4 2021 value amounting to $18000.0.

  • Immunocore Holdings' Other Operating Expenses changed N/A to $18000.0 in Q4 2021 from the same period last year, while for Mar 2023 it was $18000.0, marking a year-over-year change of. This contributed to the annual value of -$77000.0 for FY2021, which is 10181.52% down from last year.
  • As of Q4 2021, Immunocore Holdings' Other Operating Expenses stood at $18000.0.
  • Immunocore Holdings' Other Operating Expenses' 5-year high stood at $18000.0 during Q4 2021, with a 5-year trough of -$113000.0 in Q1 2021.